Jalava Karoliina, Sallinen Ville, Lampela Hanna, Malmi Hanna, Steinholt Ingeborg, Augestad Knut Magne, Leppäniemi Ari, Mentula Panu
Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Transplantation and Liver Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
JAMA Surg. 2025 May 14. doi: 10.1001/jamasurg.2025.1212.
Antibiotics are thought to decelerate inflammation progression and reduce complications in acute uncomplicated appendicitis. The evidence of their effectiveness is insufficient, and treatment practices vary widely.
To investigate the effect of preoperatively started antibiotic treatment on the rate of appendiceal perforation.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter, noninferiority, open-label randomized clinical trial was conducted in 2 hospitals in Finland and 1 hospital in Norway between May 18, 2020, and January 22, 2023. Data analysis was performed from March 2023 to March 2024. Eligible patients were adults (aged >18 years) diagnosed with presumed uncomplicated acute appendicitis. Patients with allergies or other contraindications to study antibiotics, previously started antibiotic treatment, pregnancy, a suspicion of perforated appendicitis, or other reasons to perform prompt surgery were excluded. Patients were randomized 1:1 with a web-based service simultaneously as the laparoscopic appendectomy was scheduled.
Antibiotic treatment started while waiting for surgery (cefuroxime, 1500 mg, and metronidazole, 500 mg, every 8 hours until the surgery) or waiting without antibiotic treatment. Patients in both groups received a single prophylactic dose of antibiotics in the induction of anesthesia.
The primary outcome was perforated appendicitis diagnosed during surgery. The absolute difference in perforation rates was compared between the groups by an intention-to-treat analysis, and the predefined noninferiority margin was 5 percentage points. Secondary outcomes included surgical site infections within 30 days.
A total of 1797 patients were randomly assigned to either the antibiotic group (n = 901) or no-antibiotic group (n = 896). Median (IQR) patient age was 35 (28-46) years, and 793 patients (45%) were female. After randomization, 23 patients (1.3%) were excluded, leaving 1774 patients for the intention-to-treat analyses. The difference between the appendiceal perforation rates met the noninferiority threshold: 74 of 888 patients in the antibiotic group (8.3%) vs 79 of 886 patients in the no-antibiotic group (8.9%; absolute difference, 0.6 percentage points; 95% CI, -2.0 to 3.2 percentage points; P = .66; risk ratio, 1.07; 95% CI, 0.79 to 1.45). For secondary outcome, the surgical site infection rate was slightly lower in the antibiotic group (14 of 887 [1.6%]) vs the no-antibiotic group (28 of 886 [3.2%]; absolute difference, 1.6 percentage points; 95% CI, 0.2 to 3.0 percentage points; P = .03).
In this multicenter noninferiority randomized clinical trial, preoperatively started antibiotic treatment did not decrease the risk of appendiceal perforation when appendectomy was performed within 24 hours in adult patients with presumed uncomplicated acute appendicitis.
EudraCT Identifier: 2019-002348-26.
抗生素被认为可减缓急性单纯性阑尾炎的炎症进展并减少并发症。其有效性证据不足,治疗方法差异很大。
研究术前开始使用抗生素治疗对阑尾穿孔率的影响。
设计、地点和参与者:这项多中心、非劣效性、开放标签随机临床试验于2020年5月18日至2023年1月22日在芬兰的2家医院和挪威的1家医院进行。数据分析于2023年3月至2024年3月进行。符合条件的患者为诊断为疑似单纯性急性阑尾炎的成年人(年龄>18岁)。对研究抗生素过敏或有其他禁忌证、先前已开始抗生素治疗、怀孕、怀疑阑尾穿孔或有其他需要立即手术的原因的患者被排除。患者在安排腹腔镜阑尾切除术的同时通过基于网络的服务按1:1随机分组。
在等待手术期间开始抗生素治疗(头孢呋辛1500毫克和甲硝唑500毫克,每8小时一次,直至手术)或不进行抗生素治疗等待。两组患者在麻醉诱导时均接受单次预防性抗生素剂量。
主要结局是手术期间诊断出的阑尾穿孔。通过意向性分析比较两组穿孔率的绝对差异,预先定义的非劣效性界限为5个百分点。次要结局包括30天内的手术部位感染。
共有1797例患者被随机分配到抗生素组(n = 901)或无抗生素组(n = 896)。患者年龄中位数(IQR)为35(28 - 46)岁,793例患者(45%)为女性。随机分组后,23例患者(1.3%)被排除,1774例患者纳入意向性分析。阑尾穿孔率的差异达到非劣效性阈值:抗生素组888例患者中的74例(8.3%),无抗生素组886例患者中的79例(8.9%);绝对差异为0.6个百分点;95% CI为 -2.0至3.2个百分点;P = 0.66;风险比为1.07;95% CI为0.79至1.45。对于次要结局,抗生素组的手术部位感染率略低于无抗生素组(887例中的14例[1.6%])与无抗生素组(886例中的28例[3.2%]);绝对差异为1.6个百分点;95% CI为0.2至3.0个百分点;P = 0.03。
在这项多中心非劣效性随机临床试验中,对于疑似单纯性急性阑尾炎的成年患者,在24小时内进行阑尾切除术时,术前开始使用抗生素治疗并未降低阑尾穿孔的风险。
欧洲临床试验数据库标识符:2019 - 002348 - 26。